Company intelligence / Profile preview

CIMNA

Ownership: Private
Development stage: Other

Overview

CIMNA (Center for Innovation in Medicine and Nanotechnology) is a biotechnology company focused on the development of advanced nanotechnology-based solutions for medicine. The company specializes in the design and synthesis of functionalized nanoparticles for targeted drug delivery, particularly in the fields of oncology and infectious diseases. By leveraging its proprietary nanotechnology platform, CIMNA aims to improve the therapeutic index of existing drugs and enable the delivery of novel therapeutic agents. The company's research and development efforts are centered on creating smart delivery systems that can respond to specific biological triggers within the tumor microenvironment.

Therapeutic areas: OncologyInfectious Diseases
Modalities: NanoparticleSmall moleculeDrug delivery
Industry: Biotech

Beyond the preview

Go deeper on CIMNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIMNA.

Explore the full profile